OTC label warning consolidation raised at OTC "feedback" meeting.
This article was originally published in The Tan Sheet
Executive Summary
OTC LABEL WARNING CONSOLIDATION FLOATED AS POSSIBLE SOLUTION to the space problem expected by industry from FDA's proposed requirement that labels be printed in a minimum type size of 6 points. At a May 8 OTC "feedback" meeting, Nonprescription Drug Manufacturers Association Senior VP and Scientific & Regulatory Affairs Director William Soller, PhD, asked FDA whether overcrowding might be addressed by "further" consolidating warnings by, for example, merging two warning subheadings on one line.